Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells

Brain Research

Volumn 1310, Issue , 2010, Pages 37-45

  Gortari, Patricia de ^a,b   Mengod, Guadalupe ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

Author keywords

AC5; Addiction; Double in situ hybridization; Locomotion; PDE7B

Indexed keywords

ADENYLATE CYCLASE; ADENYLATE CYCLASE 5; CYCLIC AMP; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MESSENGER RNA; MU OPIATE RECEPTOR; OPIATE RECEPTOR; PHOSPHODIESTERASE VII; PHOSPHODIESTERASE VIIB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CAUDATE NUCLEUS; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; IN SITU HYBRIDIZATION; LOCOMOTION; MALE; NEUROBIOLOGY; NEUROCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANALYSIS OF VARIANCE; ANIMALS; CORPUS STRIATUM; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 7; MALE; NEURONS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, OPIOID, MU; RNA, MESSENGER;

RATTUS;

EID: 73349100320     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.11.009     Document Type: Article

References (42)

1. Barnes M.J., Cooper N., Davenport R.J., Dyke H.J., Galleway F.P., Galvin F.C., et al. Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors. Bioorg. Med. Chem. Lett. 11 (2001) 1081-1083
2. Barrot M., Olivier J.D., Perrotti L.I., DiLeone R.J., Berton O., Eisch A.J., et al. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11435-11440
3. Bouron A., and Reuter H. The D1 dopamine receptor agonist SKF-38393 stimulates the release of glutamate in the hippocampus. Neuroscience 94 (1999) 1063-1070
4. Byrnes E.M., Bridges R.S., Scanlan V.F., Babb J.A., and Byrnes J.J. Sensorimotor gating and dopamine function in postpartum rats. Neuropsychopharmacology 32 (2007) 1021-1031
5. Chen C., and Regehr W.G. The mechanism of cAMP-mediated enhancement at a cerebellar synapse. J. Neurosci. 17 (1997) 8687-8694
6. Conti M., and Jin S.L. The molecular biology of cyclic nucleotide phosphodiesterases. Prog. Nucleic Acid Res. Mol. Biol. 63 (1999) 1-38
7. Coskran T.M., Morton D., Menniti F.S., Adamowicz W.O., Kleiman R.J., Ryan A.M., et al. Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species. J. Histochem. Cytochem. 54 (2006) 1205-1213
8. Defer N., Best-Belpomme M., and Hanoune J. Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am. J. Physiol. Renal Physiol. 279 (2000) F400-416
9. Frey U., Huang Y.Y., and Kandel E.R. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 260 (1993) 1661-1664
10. Glatt C.E., and Snyder S.H. Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature 361 (1993) 536-538
11. Hanoune J., and Defer N. Regulation and role of adenylyl cyclase isoforms. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 145-174
12. Houslay M.D., and Milligan G. Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem. Sci. 22 (1997) 217-224
13. Kandel E.R., and Schwartz J.H. Molecular biology of learning: modulation of transmitter release. Science 218 (1982) 433-443
14. Kim K.S., Lee K.W., Baek I.S., Lim C.M., Krishnan V., Lee J.K., et al. Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior. J. Neurochem. 107 (2008) 105-115
15. Kim K.S., Lee K.W., Lee K.W., Im J.Y., Yoo J.Y., Kim S.W., et al. Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3908-3913
16. Koob G.F. Neural mechanisms of drug reinforcement. Ann. N. Y. Acad. Sci. 654 (1992) 171-191
17. Lalli E., and Sassone-Corsi P. Signal transduction and gene regulation: the nuclear response to cAMP. J. Biol. Chem. 269 (1994) 17359-17362
18. Landry M., Holmberg K., Zhang X., and Hokfelt T. Effect of axotomy on expression of NPY, galanin, and NPY Y1 and Y2 receptors in dorsal root ganglia and the superior cervical ganglion studied with double-labeling in situ hybridization and immunohistochemistry. Exp. Neurol. 162 (2000) 361-384
19. Lee K.W., Hong J.H., Choi I.Y., Che Y., Lee J.K., Yang S.D., et al. Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase. J. Neurosci. 22 (2002) 7931-7940
20. Mansour A., Fox C.A., Thompson R.C., Akil H., and Watson S.J. mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res 643 (1994) 245-265
21. Matsuoka I., Suzuki Y., Defer N., Nakanishi H., and Hanoune J. Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain. J. Neurochem. 68 (1997) 498-506
22. McGinty J.F., and Wang J.Q. Drugs of abuse and striatal gene expression. Adv. Pharmacol. 42 (1998) 1017-1019
23. Mengod G., Martinez-Mir M.I., Vilaro M.T., and Palacios J.M. Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 8560-8564
24. Mengod G., Vilaro M.T., Niznik H.B., Sunahara R.K., Seeman P., O'Dowd B.F., et al. Visualization of a dopamine D1 receptor mRNA in human and rat brain. Brain Res. Mol. Brain Res. 10 (1991) 185-191
25. Menniti F.S., Faraci W.S., and Schmidt C.J. Phosphodiesterases in the CNS: targets for drug development. Nat. Rev. Drug Discov. 5 (2006) 660-670
26. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 Suppl. 1 (2004) 24-32
27. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25 (2004) 210-218
28. Nestler E.J., and Aghajanian G.K. Molecular and cellular basis of addiction. Science 278 (1997) 58-63
29. Paxinos G., and Watson C. The Rat Brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, San Diego
30. Pompeiano M., Palacios J.M., and Mengod G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J. Neurosci. 12 (1992) 440-453
31. Reyes-Irisarri E., Perez-Torres S., and Mengod G. Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain. Neuroscience 132 (2005) 1173-1185
32. Sasaki T., Kotera J., and Omori K. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons. J. Neurochem. 89 (2004) 474-483
33. Schmidt U., Pilgrim C., and Beyer C. Differentiative effects of dopamine on striatal neurons involve stimulation of the cAMP/PKA pathway. Mol. Cell. Neurosci. 11 (1998) 9-18
34. Schmitz E., Mohr E., and Richter D. Rat vasopressin and oxytocin genes are linked by a long interspersed repeated DNA element (LINE): sequence and transcriptional analysis of LINE. DNA Cell. Biol. 10 (1991) 81-91
35. Seeger T.F., Bartlett B., Coskran T.M., Culp J.S., James L.C., Krull D.L., et al. Immunohistochemical localization of PDE10A in the rat brain. Brain Res. 985 (2003) 113-126
36. Serrats J., Artigas F., Mengod G., and Cortes R. GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase. J. Neurochem. 84 (2003) 743-752
37. Tomiyama M., Palacios J.M., Cortes R., Vilaro M.T., and Mengod G. Distribution of AMPA receptor subunit mRNAs in the human basal ganglia: an in situ hybridization study. Brain Res. Mol. Brain Res. 46 (1997) 281-289
38. Tully T., Bourtchouladze R., Scott R., and Tallman J. Targeting the CREB pathway for memory enhancers. Nat. Rev. Drug Discov. 2 (2003) 267-277
39. Weber M., Breier M., Ko D., Thangaraj N., Marzan D.E., and Swerdlow N.R. Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine. Psychopharmacology (Berl.) 203 (2009) 723-735
40. Yamashita N., Hayashi A., Baba J., and Sawa A. Rolipram, a phosphodiesterase-4-selective inhibitor, promotes the survival of cultured rat dopaminergic neurons. Jpn. J. Pharmacol. 75 (1997) 155-159
41. Yang G., McIntyre K.W., Townsend R.M., Shen H.H., Pitts W.J., Dodd J.H., et al. Phosphodiesterase 7A-deficient mice have functional T cells. J. Immunol. 171 (2003) 6414-6420
42. Zhong Y., and Wu C.F. Altered synaptic plasticity in Drosophila memory mutants with a defective cyclic AMP cascade. Science 251 (1991) 198-201